[go: up one dir, main page]

PE20150908A1 - Fortificador de la formula - Google Patents

Fortificador de la formula

Info

Publication number
PE20150908A1
PE20150908A1 PE2015000253A PE2015000253A PE20150908A1 PE 20150908 A1 PE20150908 A1 PE 20150908A1 PE 2015000253 A PE2015000253 A PE 2015000253A PE 2015000253 A PE2015000253 A PE 2015000253A PE 20150908 A1 PE20150908 A1 PE 20150908A1
Authority
PE
Peru
Prior art keywords
fortifier
component
formula
premature babies
proteins
Prior art date
Application number
PE2015000253A
Other languages
English (en)
Inventor
Carol Lynn Berseth
Kelly R Walsh
Deborah A Schade
Ana Cecilia Munoz-Espada
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48953455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20150908(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20150908A1 publication Critical patent/PE20150908A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invencion proporciona un fortificador de la formula para bebes prematuros que comprende un componente de proteina, un componente de grasa, y un componente de hidratos de carbono, en el que entre aproximadamente 10 a 30% del contenido calorico del fortificador proviene de las proteinas. Tambien se proporciona una composicion para administrarlo en bebes prematuros, que comprende i) un fortificador de la formula para bebes prematuros que comprende un componente de proteina, un componente de grasa, y un componente de hidratos de carbono, en el que aproximadamente entre 10 a 30% del contenido calorico del fortificador proviene de las proteinas y ii) una formula para bebes prematuros
PE2015000253A 2012-08-27 2013-07-30 Fortificador de la formula PE20150908A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/595,296 US20140057014A1 (en) 2012-08-27 2012-08-27 Formula Fortifier

Publications (1)

Publication Number Publication Date
PE20150908A1 true PE20150908A1 (es) 2015-07-02

Family

ID=48953455

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000253A PE20150908A1 (es) 2012-08-27 2013-07-30 Fortificador de la formula

Country Status (18)

Country Link
US (1) US20140057014A1 (es)
EP (1) EP2887824A1 (es)
CN (2) CN104540398A (es)
AR (1) AR092187A1 (es)
AU (1) AU2013309437B2 (es)
BR (1) BR112015002606A2 (es)
CA (1) CA2880861C (es)
CO (1) CO7310519A2 (es)
HK (1) HK1209287A1 (es)
IN (1) IN2015DN00102A (es)
MX (1) MX2015000690A (es)
MY (1) MY173927A (es)
PE (1) PE20150908A1 (es)
PH (1) PH12015500683A1 (es)
RU (1) RU2015109670A (es)
SG (1) SG11201408840YA (es)
TW (1) TW201424592A (es)
WO (1) WO2014035582A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3082470A1 (en) * 2013-11-29 2016-10-26 Nestec S.A. Liquid milk fortifier composition with relatively high lipid content
US12096785B2 (en) 2018-02-19 2024-09-24 Abbott Laboratories Lipid emulsion nutritional product
CN109757686B (zh) * 2019-02-27 2022-05-31 东莞百润生物科技有限公司 一种含n-乙酰神经氨酸的蛋白粉食品及其制备方法
CN109793044A (zh) * 2019-03-21 2019-05-24 贝因美（杭州）食品研究院有限公司 一种适用于早产/低出生体重婴儿食用的配方奶粉及其制备方法
WO2021035854A1 (zh) * 2019-08-28 2021-03-04 苏州大学附属儿童医院 Vlbwi营养管理用特配液及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140304A (en) * 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5418010A (en) * 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
AU661297B2 (en) 1991-01-24 1995-07-20 Martek Corporation Microbial oil mixtures and uses thereof
CN1191828C (zh) * 1997-03-27 2005-03-09 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6541061B2 (en) * 2000-04-07 2003-04-01 Monsanto Technology Llc Low calorie fat compositions
US20030203097A1 (en) * 2002-04-24 2003-10-30 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
AU2004279621A1 (en) * 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US20070243290A1 (en) * 2006-04-18 2007-10-18 Melody Thompson Method of tailoring infant formulas to individual nutritional needs prior to use
US20100119617A1 (en) * 2007-03-29 2010-05-13 The Hospital For Sick Children Multi-nutrient milk fortifier
MY150223A (en) * 2007-05-18 2013-12-31 Mjn Us Holdings Llc Acidified liquid human milk supplement
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
WO2011144221A1 (en) * 2010-05-18 2011-11-24 N.V. Nutricia Preterm milk formula
EP2612560A1 (en) * 2012-01-09 2013-07-10 N.V. Nutricia Glutamine enriched nutritional composition for preterm infants

Also Published As

Publication number Publication date
HK1209287A1 (en) 2016-04-01
CA2880861A1 (en) 2014-03-06
SG11201408840YA (en) 2015-01-29
CN108902943A (zh) 2018-11-30
MX2015000690A (es) 2015-04-08
IN2015DN00102A (es) 2015-05-29
AU2013309437B2 (en) 2016-09-01
RU2015109670A (ru) 2016-10-20
CA2880861C (en) 2020-07-07
TW201424592A (zh) 2014-07-01
CN104540398A (zh) 2015-04-22
AR092187A1 (es) 2015-04-08
US20140057014A1 (en) 2014-02-27
CO7310519A2 (es) 2015-06-30
BR112015002606A2 (pt) 2017-07-04
AU2013309437A1 (en) 2015-01-29
WO2014035582A1 (en) 2014-03-06
PH12015500683A1 (en) 2015-05-18
MY173927A (en) 2020-02-27
EP2887824A1 (en) 2015-07-01

Similar Documents

Publication Publication Date Title
BR112016029906A2 (pt) compostos excipientes redutores de viscosidade para formulações proteicas
BR112018012707A2 (pt) inibidores da interação de menin-mll
PE20150201A1 (es) Proteinas del factor 21 de crecimiento del fibroblasto
BR112014024903A2 (pt) anticorpos biespecíficos contra tweak humanao e il17 humana e seus usos
BR112015021888A2 (pt) inibidores de dna-ik
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CO6680687A2 (es) Inmunoglobinas con dominio variable dual capaces de unirse a il 1 beta e il-17, composiciones farmaceúticas y conjugados de proteína de unión de las mismas
BR112016020368A2 (pt) proteínas fc multiméricas
CL2019002190A1 (es) Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984)
CL2011003003A1 (es) Composicion tensioactiva reconstituida que comprende un polipeptido análogo a la proteína surfactante c nativa, un polipeptido análogo a la proteína surfactante b nativa, un fosfolipido monoinsaturado y un fosfolipido saturado, útil para el tratamiento del síndrome de dificultad respiratoria.
AR095021A1 (es) Composiciones de azúcares mixtos
EA201591524A1 (ru) Производные 2-аминопиримидина для лечения вирусных инфекций
EA201591166A1 (ru) Ингибиторы аутотаксина
BR112017001796A2 (pt) composições de flagelina e seus usos
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
MX2015001553A (es) Composiciones y metodos para reducir el contenido de alcohol en sangre.
AR104835A1 (es) Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas
EA202090683A2 (ru) Способы и композиции для лечения рака
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
BR112015024040A2 (pt) preparação alergênica
CL2015002835A1 (es) Nuevos derivados de piridina
PE20150908A1 (es) Fortificador de la formula
CL2013003003A1 (es) Uso de fórmula infantil que comprende al menos una fuente de proteínas, una fuente de lípidos, una fuente de carbohidratos, con 1,6-1,85 g/100 kcal que sirve para preparar un medicamento útil en la prevención de la presión sanguínea elevada o de las enfermedades cardiovasculares.
AR105237A1 (es) Método y composiciones nutricionales que contienen fosfatidiletanolamina, esfingomielina y ácido docosahexaenoico
EA201692402A1 (ru) Лекарственные формы для местного применения и их использование

Legal Events

Date Code Title Description
FD Application declared void or lapsed